Published in Invest Urol on November 01, 1967
Natural pathology of the captive chimpanzee (Pan troglodytes): A 35-year review. J Med Primatol (2017) 0.75
'Green revolution' genes encode mutant gibberellin response modulators. Nature (1999) 8.87
The Arabidopsis GAI gene defines a signaling pathway that negatively regulates gibberellin responses. Genes Dev (1997) 7.30
LNCaP model of human prostatic carcinoma. Cancer Res (1983) 7.23
Is the new veterinary college a good model? J Am Vet Med Assoc (1998) 5.86
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol (2000) 3.38
Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer (1980) 3.37
Purification of a human prostate specific antigen. Invest Urol (1979) 3.11
The use of a DNA probe for epidemiological studies of candidiasis in immunocompromised hosts. J Infect Dis (1989) 2.98
Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. Ann Intern Med (1982) 2.97
Isolation and characterization of a lymphatic leukemia virus in the Friend virus complex. J Natl Cancer Inst (1971) 2.94
Carcinoembryonic antigen in patients with different cancers. JAMA (1972) 2.56
Restoration of fertility to oophorectomized sheep by ovarian autografts stored at -196 degrees C. Hum Reprod (1994) 2.48
Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin (1993) 2.43
From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis (1990) 2.39
Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases. Cancer (1998) 2.15
Trichosporonosis in patients with neoplastic disease. Medicine (Baltimore) (1986) 2.11
Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside. Lancet (1978) 2.10
Prostate-specific membrane antigen expression is greatest in prostate adenocarcinoma and lymph node metastases. Urology (1998) 2.04
American Joint Committee on Cancer prognostic factors consensus conference. Cancer (1999) 2.02
Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res (1988) 1.91
Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med (1983) 1.90
SV40 neutralizing antibodies in sera of US residents without history of polio immunization. Nature (1971) 1.77
Race-related differences in breast cancer patients. Results of the 1982 national survey of breast cancer by the American College of Surgeons. Cancer (1985) 1.76
Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer (1981) 1.73
Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer. Prostate (1999) 1.71
Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Ann Intern Med (1982) 1.67
Secondary carcinomas of the kidney. J Urol (1975) 1.59
The National Cancer Data base Report on increased use of brachytherapy for the treatment of patients with prostate carcinoma in the U.S. Cancer (1999) 1.58
Clinical highlights from the National Cancer Data Base: 1994. CA Cancer J Clin (1994) 1.58
Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 1.56
The 1982 national survey of carcinoma of the breast in the United States by the American College of Surgeons. Surg Gynecol Obstet (1984) 1.54
Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients. Am J Med (1981) 1.53
Spleen focus formation by polycythemic strains of Friend leukemia virus. Proc Soc Exp Biol Med (1968) 1.49
Prolonged venous access for chemotherapy by means of the Hickman catheter. Cancer (1983) 1.49
Two mechanisms for growth inhibition by elevated transport of sugar phosphates in Escherichia coli. J Gen Microbiol (1992) 1.48
The National Cancer Data Base report on race, age, and region variations in prostate cancer treatment. Cancer (1997) 1.47
Infections in cancer patients: some controversial issues. Support Care Cancer (1994) 1.46
Cost-effective prostate cancer detection. Reduction of low-yield biopsies. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer (1994) 1.46
Treatment of cytomegalovirus pneumonia with high-dose acyclovir. Am J Med (1982) 1.41
The American Cancer Society National Prostate Cancer Detection Project. Findings on the detection of early prostate cancer in 2425 men. Cancer (1991) 1.39
Measuring response to a cancer information telephone facility: Can-Dial. Am J Public Health (1976) 1.39
Rapid assay of murine leukemia virus helper activity for Friend spleen focus-forming virus. J Natl Cancer Inst (1971) 1.37
Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer (1988) 1.35
CEA as a monitor of gastrointestinal malignancy. Cancer (1975) 1.33
Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Ann Intern Med (1984) 1.31
CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells. J Surg Oncol (1998) 1.29
Adherent microorganisms on lumenal surfaces of long-term intravenous catheters. Importance of Staphylococcus epidermidis in patients with cancer. Arch Intern Med (1986) 1.29
Trends in patterns of care for prostatic cancer, 1974-1983: results of surveys by the American College of Surgeons. J Urol (1986) 1.29
Noninvasive breast carcinoma: results of a national survey by the American College of Surgeons. Ann Surg (1980) 1.27
Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer. Cancer (1993) 1.27
The results of a five-year early prostate cancer detection intervention. Investigators of the American Cancer Society National Prostate Cancer Detection Project. Cancer (1996) 1.25
Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir. J Infect Dis (1983) 1.23
The association of benign prostatic hyperplasia and cancer of the prostate. Cancer (1992) 1.22
Can-Dial. An experiment in health education and cancer control. Public Health Rep (1976) 1.20
Prostate antigen: a new potential marker for prostatic cancer. Prostate (1981) 1.18
Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients. Prostate Suppl (1996) 1.17
Mechanism of testosterone action in erythropoiesis. Nature (1965) 1.16
Bacillus infections in patients with cancer. Arch Intern Med (1988) 1.16
Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host. Am J Med (1982) 1.16
A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia. N Engl J Med (1981) 1.15
Can-Dial: a dial access cancer education service. Int J Health Educ (1977) 1.14
Utilization of a cancer telephone information facility: a comparison of callers and non-caller controls. Am J Public Health (1978) 1.13
The National Cancer Data Base report on bladder carcinoma. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer (1996) 1.13
Selective suppression of alimentary tract microbial flora as prophylaxis during granulocytopenia. Antimicrob Agents Chemother (1981) 1.13
Correlations of the orthogonal electrocardiogram and vectorcardiogram with consitutional variables in 518 normal men. Circulation (1967) 1.12
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin. Am J Med (1982) 1.12
Steady-state pharmacokinetics of imipenem in febrile neutropenic cancer patients. Antimicrob Agents Chemother (1987) 1.12
In vitro production of erythropoietin by mouse fetal liver. Blood (1975) 1.11
Follow-up evaluation of a phase II prostate cancer vaccine trial. Prostate (1999) 1.11
Treatment of cytomegaloviral pneumonia with high-dose acyclovir and human leukocyte interferon. J Infect Dis (1983) 1.11
Use of human prostate-specific antigen in monitoring prostate cancer. Cancer Res (1981) 1.10
Mutant Sl alleles of mice affect susceptibility to Friend spleen focus-forming virus. Science (1968) 1.10
A murine renal cell carcinoma. J Natl Cancer Inst (1973) 1.09
Why is the prostate cancer death rate declining in the United States? Cancer (1998) 1.09
Murine viral-induced polycyhemia. Ann N Y Acad Sci (1968) 1.09
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides. Prostate (1998) 1.09
Virus-induced polycythemia in mice: erythropoiesis without erythropoietin. Proc Soc Exp Biol Med (1968) 1.08
A prostate antigen in sera of prostatic cancer patients. Cancer Res (1980) 1.08
The use of acyclovir for cytomegalovirus infections in the immunocompromised host. J Antimicrob Chemother (1983) 1.08
Genetic control by the W locus of susceptibility to (Friend) spleen focus-forming virus. Nature (1968) 1.08
Matrix metalloproteinase homologues from Arabidopsis thaliana. Expression and activity. J Biol Chem (1999) 1.07
Management and survival of carcinoma of the colon: results of a national survey by the American College of Surgeons. Ann Surg (1978) 1.07
Enhancement of spleen focus formation and virus replication in Friend virus-infected mice. Cancer Res (1969) 1.07
Cancer information by telephone: a two-year evaluation. Health Educ Monogr (1977) 1.07
Prostate cancer: progress and change. CA Cancer J Clin (1978) 1.06
Vertical transmission of murine leukemia virus. Cancer Res (1969) 1.06
Identification of erythropoietin producing cells in fetal mouse liver cultures. Exp Hematol (1977) 1.06
The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on Cancer. Cancer (1979) 1.05
A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program. Cancer (1997) 1.05
Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides. Prostate (1997) 1.05
Trends in prostate cancer care in the United States, 1974-1990: observations from the patient care evaluation studies of the American College of Surgeons Commission on Cancer. CA Cancer J Clin (1993) 1.05
Prostate-specific membrane antigen: current and future utility. Semin Urol Oncol (1998) 1.04
Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res (1980) 1.04
The National Cancer Data Base report on longitudinal observations on prostate cancer. Cancer (1996) 1.04
Prostate-specific antigen levels in young white and black men 20 to 45 years old. Urology (2000) 1.04
The national survey of prostate cancer in the United States by the American College of Surgeons. J Urol (1982) 1.04